advertisement
Le Pen C 1
Showing records 1 to 1 | Display all abstracts from Le Pen C12216 Cost-effectiveness and cost-utility analysis of travoprost versus latanoprost and timolol in the treatment of advanced glaucoma in five European countries: Austria, France, Germany, The Netherlands and the United Kingdom
Le Pen C; Ligier M; Berdeaux G
Journal of Medical Economics 2005; 8: 67-84
